Survival Analysis of Pathological T3a Upstaging in Clinical T1 Renal Cell Carcinoma

被引:5
作者
Lai, Gu-Shun [1 ]
Li, Jian-Ri [2 ,3 ,4 ]
Wang, Shian-Shiang [2 ,3 ,5 ]
Chen, Chuan-Shu [2 ,3 ]
Yang, Chun-Kuang [2 ]
Hung, Sheng-Chun [2 ,3 ]
Cheng, Chen-Li [2 ,3 ]
Ou, Yen-Chuan [3 ,6 ]
Chiu, Kun-Yuan [2 ,5 ]
机构
[1] Taichung Vet Gen Hosp, Chiayi Branch, Dept Surg, Div Urol, Chiayi, Taiwan
[2] Taichung Vet Gen Hosp, Dept Surg, Div Urol, Taichung, Taiwan
[3] Chung Shan Med Univ, Inst Med, Taichung, Taiwan
[4] Hungkuang Univ, Dept Med & Nursing, Taichung, Taiwan
[5] Natl Chi Nan Univ, Dept Appl Chem, Nantou, Taiwan
[6] Tungs Taichung MetroHarbor Hosp, Dept Urol, Taichung, Taiwan
来源
IN VIVO | 2020年 / 34卷 / 02期
关键词
Pathological T3a upstaging; renal cell carcinoma; survival; POSITIVE SURGICAL MARGINS; PARTIAL NEPHRECTOMY; RECURRENCE; MASSES; GUIDELINES; PREDICTORS; SURGERY; IMPACT;
D O I
10.21873/invivo.11841
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aim: To evaluate the oncological outcomes of pathological T3a upstaging from clinical T1 renal cell carcinoma. Patients and Methods: We retrospectively studied patients who underwent radical or partial nephrectomy for clinical T1 renal tumors. Results: The median follow-up period was 44 months. At three and five years, the respective overall survival rate was 88.7% and 82.4% in pT3a disease, 95.7% and 93.4% in pT1 (p=0.008), the cancer-specific survival rate, 93.9% and 90.8% in pT3a, 99% and 97.7% in pT1 (p=0.001), and the recurrence-free survival rate, 79.7% and 71.0% in pT3a, and 95.5 and 94.3% in pT1 (p<0.001). Conclusion: Patients with pathological T3a upstaging tumors were associated with a significantly decreased survival rate, along with a higher recurrence rate when compared to those with pathological T1 disease.
引用
收藏
页码:799 / 805
页数:7
相关论文
共 23 条
[1]  
Aufderklamm S, 2016, ANTICANCER RES, V36, P2865
[2]   Guideline for Management of the Clinical T1 Renal Mass [J].
Campbell, Steven C. ;
Novick, Andrew C. ;
Belldegrun, Arie ;
Blute, Michael L. ;
Chow, George K. ;
Derweesh, Ithaar H. ;
Faraday, Martha M. ;
Kaouk, Jihad H. ;
Leveillee, Raymond J. ;
Matin, Surena F. ;
Russo, Paul ;
Uzzo, Robert G. .
JOURNAL OF UROLOGY, 2009, 182 (04) :1271-1279
[3]   Impact of clinicopathological parameters in patients treated for renal cell carcinoma [J].
Dall'Oglio, Marcos F. ;
Arap, Marco A. ;
Antunes, Alberto A. ;
Cury, Jose ;
Leite, Katia R. ;
Srougi, Miguel .
JOURNAL OF UROLOGY, 2007, 177 (05) :1687-1690
[4]   Pathological High-risk Renal Cell Carcinoma: Trends in Clinical Characteristics Over 25 Years [J].
Di Trapani, Ettore ;
Dell'Oglio, Paolo ;
Larcher, Alessandro ;
Nini, Alessandro ;
Muttin, Fabio ;
Cianflone, Francesco ;
Deho, Federico ;
Matloob, Rayan ;
Di Trapani, Dario ;
Freschi, Massimo ;
Salonia, Andrea ;
Briganti, Alberto ;
Montorsi, Francesco ;
Bertini, Roberto ;
Capitanio, Umberto .
ANTICANCER RESEARCH, 2018, 38 (07) :4123-4130
[5]  
Marchiñena PG, 2018, INT BRAZ J UROL, V44, P475, DOI [10.1590/S1677-5538.IBJU.2017.0039, 10.1590/s1677-5538.ibju.2017.0039]
[6]   Outcomes and Predictors of Clinical T1 to Pathological T3a Tumor Up-Staging after Robotic Partial Nephrectomy: A Multi- Institutional Analysis [J].
Gorin, Michael A. ;
Ball, Mark W. ;
Pierorazio, Phillip M. ;
Tanagho, Youssef S. ;
Bhayani, Sam B. ;
Kaouk, Jihad H. ;
Rogers, Craig G. ;
Stifelman, Michael D. ;
Khalifeh, Ali ;
Kumar, Ramesh ;
Sivarajan, Ganesh ;
Allaf, Mohamad E. .
JOURNAL OF UROLOGY, 2013, 190 (05) :1907-1911
[7]   Rising incidence of small renal masses: A need to reassess treatment effect [J].
Hollingsworth, John M. ;
Miller, David C. ;
Daignault, Stephanie ;
Hollenbeck, Brent K. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (18) :1331-1334
[8]   Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging [J].
Jeong, Seung-hwan ;
Kim, Jung Kwon ;
Park, Juhyun ;
Jeon, Ho Joon ;
Yoon, Min Young ;
Jeong, Chang Wook ;
Ku, Ja Hyeon ;
Kim, Hyeon Hoe ;
Kwak, Cheol .
PLOS ONE, 2016, 11 (11)
[9]   Surgical Margin Does Not Influence Recurrence Rate in pT1 Clear Cell Renal Cell Carcinoma After Partial Nephrectomy: A Multicenter Study [J].
Kang, Ho Won ;
Lee, Sang Keun ;
Kim, Won Tae ;
Yun, Seok Joong ;
Lee, Sang-Cheol ;
Kim, Wun-Jae ;
Hwang, Eu Chang ;
Kang, Seok Ho ;
Hong, Sung-Hoo ;
Chung, Jinsoo ;
Kwon, Tae Gyun ;
Kim, Hyeon Hoe ;
Kwak, Cheol ;
Byun, Seok-Soo ;
Kim, Yong-June .
JOURNAL OF SURGICAL ONCOLOGY, 2016, 114 (01) :70-74
[10]   Prognostic factors in renal cell carcinoma [J].
Kontak, JA ;
Campbell, SC .
UROLOGIC CLINICS OF NORTH AMERICA, 2003, 30 (03) :467-+